Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 363 | 3 | RENIN ANGIOTENSIN SYSTEM//ANGIOTENSIN II//BRADYKININ | 35741 |
| 2089 | 2 | HEREDITARY ANGIOEDEMA//ANGIOEDEMA//C1 INHIBITOR | 5570 |
| 24978 | 1 | IMIDAPRIL//IMIDAPRIL HYDROCHLORIDE//IMIDAPRILAT | 318 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | IMIDAPRIL | authKW | 1035984 | 9% | 37% | 28 |
| 2 | IMIDAPRIL HYDROCHLORIDE | authKW | 594654 | 2% | 100% | 6 |
| 3 | IMIDAPRILAT | authKW | 247767 | 2% | 50% | 5 |
| 4 | PHARMACOKINETICS AND PHARMACODYNAMICS PK PD | authKW | 198218 | 1% | 100% | 2 |
| 5 | COUGH | authKW | 161723 | 16% | 3% | 51 |
| 6 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS | authKW | 116278 | 19% | 2% | 62 |
| 7 | 24 HOUR MONITORING OF ARTERIAL PRESSURE | authKW | 99109 | 0% | 100% | 1 |
| 8 | 4S 1 METHYL 3 2S 2 N 1S 1 ETHOXYCARBONYL 3 PHENYLPROPYLAMINO PROPIONYL 2 OXOIMIDAZOLIDINE 4 CARBOXYLIC ACID H | authKW | 99109 | 0% | 100% | 1 |
| 9 | 4S 3 2S 2N 1S 1 CARBOXY 3 PHENYLPROPYLAMINOPROPIONYL 1 METHYL 2OXOIMIDAZOLIDINE 4 CARBOXYLIC ACID PHARMACOLOG | authKW | 99109 | 0% | 100% | 1 |
| 10 | 6366A | authKW | 99109 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 1479 | 40% | 0% | 128 |
| 2 | Peripheral Vascular Diseases | 596 | 13% | 0% | 42 |
| 3 | Medicine, General & Internal | 529 | 20% | 0% | 63 |
| 4 | Respiratory System | 345 | 9% | 0% | 29 |
| 5 | Critical Care Medicine | 139 | 4% | 0% | 14 |
| 6 | Cardiac & Cardiovascular System | 130 | 9% | 0% | 29 |
| 7 | Allergy | 79 | 3% | 0% | 8 |
| 8 | Primary Health Care | 23 | 1% | 0% | 3 |
| 9 | Medicine, Research & Experimental | 14 | 4% | 0% | 12 |
| 10 | Chemistry, Medicinal | 11 | 3% | 0% | 8 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | ABT PNEUMOLRUHRLANDKLIN | 99109 | 0% | 100% | 1 |
| 2 | CARDIOVASC DISCOVERY UNIT | 99109 | 0% | 100% | 1 |
| 3 | COGENITAL HEART SURG | 99109 | 0% | 100% | 1 |
| 4 | CORP DRUG SAFETY EPIDEMIOL | 99109 | 0% | 100% | 1 |
| 5 | EUSKAL ERICO UNIBERSITATAE | 99109 | 0% | 100% | 1 |
| 6 | FOOD DRUGS SAFETY | 99109 | 0% | 100% | 1 |
| 7 | HEAD LUNGS | 99109 | 0% | 100% | 1 |
| 8 | IMAM REFERRAL HOSP | 99109 | 0% | 100% | 1 |
| 9 | MED SCI SERV MED | 99109 | 0% | 100% | 1 |
| 10 | NETHERLANDS HEALTHCARE | 99109 | 0% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF HUMAN HYPERTENSION | 3193 | 3% | 0% | 11 |
| 2 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 3065 | 5% | 0% | 16 |
| 3 | JOURNAL OF HYPERTENSION | 1444 | 4% | 0% | 12 |
| 4 | WISCONSIN MEDICAL JOURNAL | 1319 | 0% | 1% | 1 |
| 5 | HYPERTENSION RESEARCH-CLINICAL AND EXPERIMENTAL | 1222 | 0% | 1% | 1 |
| 6 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 1109 | 3% | 0% | 9 |
| 7 | AMERICAN JOURNAL OF HYPERTENSION | 1042 | 3% | 0% | 8 |
| 8 | JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM | 994 | 1% | 0% | 3 |
| 9 | PHARMACOGENETICS AND GENOMICS | 760 | 1% | 0% | 3 |
| 10 | DRUG SAFETY | 734 | 1% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |